![Daniel Yadegar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Yadegar
Direktor/Vorstandsmitglied bei
LUMOS PHARMA, INC.
Profil
Daniel Yadegar is the founder of Newpath Management LP, founded in 2018.
Dr. Yadegar currently holds the positions of Director at Lumos Pharma, Inc. and Managing Partner at Double Point Ventures LLC.
Dr. Yadegar completed undergraduate education at Harvard University in 1999 and graduate education at Weill Cornell Medical College in 2004.
Aktive Positionen von Daniel Yadegar
| Unternehmen | Position | Beginn |
|---|---|---|
| LUMOS PHARMA, INC. | Direktor/Vorstandsmitglied | - |
Newpath Management LP
 Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Gründer | 01.09.2018 |
Ausbildung von Daniel Yadegar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
100
+
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newpath Management LP
Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Finance |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
